|
Volumn 365, Issue 24, 2011, Pages 2340-2342
|
Combined C3b and factor B autoantibodies and MPGN type II
a b b a c d e a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE;
ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE ANTIBODY;
AUTOANTIBODY;
COMPLEMENT COMPONENT C3;
COMPLEMENT COMPONENT C3 B ANTIBODY;
COMPLEMENT COMPONENT C3A;
COMPLEMENT FACTOR H;
COMPLEMENT FACTOR H ANTIBODY;
GLUCOCORTICOID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NEPHRITIC FACTOR;
RITUXIMAB;
TACROLIMUS;
UNCLASSIFIED DRUG;
COMPLEMENT COMPONENT C3B;
ADULT;
CASE REPORT;
CHILD;
COMPLEMENT ACTIVATION;
COMPLEMENT DEPOSITION;
DISEASE COURSE;
ENZYME ACTIVITY;
FEMALE;
GENE DELETION;
GENE MUTATION;
GLOMERULOPATHY;
GLOMERULUS BASEMENT MEMBRANE;
HUMAN;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
LETTER;
MALE;
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE II;
PLASMAPHERESIS;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
PROGNOSIS;
SCHOOL CHILD;
SURVIVAL;
TREATMENT OUTCOME;
AUTOIMMUNE DISEASE;
BLOOD;
IMMUNOLOGY;
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;
AUTOANTIBODIES;
AUTOIMMUNE DISEASES;
CHILD;
COMPLEMENT C3B;
COMPLEMENT FACTOR B;
FEMALE;
GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE;
HUMANS;
MALE;
PLASMA EXCHANGE;
YOUNG ADULT;
|
EID: 84855161508
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1107484 Document Type: Letter |
Times cited : (83)
|
References (5)
|